Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- 2019 (1)
- Acute hyperkalemia (1)
- Acute hyperkalemia managementZS-9 (1)
- Anti-neoplastic agents (1)
- Antineoplastic medications (1)
-
- Commencement (1)
- Graduation Program (1)
- Immunologic dose-response relationship (1)
- Infusion center (1)
- Infusion-related reactions (1)
- LLU (1)
- One Hundred and Thirteenth Year (1)
- Pre-treatment medications (1)
- Silicates-therapeutic use (1)
- Sodium zirconium cyclosilicate (1)
- Zirconium-therapeutic use (1)
- Publication
Articles 1 - 3 of 3
Full-Text Articles in Pharmacy and Pharmaceutical Sciences
Commencement Program 2019, Loma Linda University
Commencement Program 2019, Loma Linda University
Commencement Programs
CONTENTS
1 | Message from the President
3 | 2019 Events of Commencement
5 | The Academic Procession
7 | Significance of Academic Regalia
9 | The Good Samaritan
10 | University History Highlights
12 | Loma Linda University Song - "Healing Love"
13 | Criteria for Institutional Awards—Loma Linda University and Loma Linda University Health
15 | Loma Linda University Health and Loma Linda University Honorees
34 | The Programs, The School Honorees, and The Speakers
- School of Medicine, 35
- School of Pharmacy, 66
- School of Dentistry, 79
- School of Allied Health Professions - Allied Health Studies, Cardiopulmonary Sciences, …
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Pharmacy Posters
Introduction
- Infusion-related reactions (IRRs) are well-known adverse drug reactions of many biological agents and antineoplastic medications
- While typically mild-to-moderate in intensity, IRRs can be severe, with potentially life-threatening consequences requiring urgent interventions
- Appropriate use of pre-treatment medications, such as corticosteroids, antihistamines, intravenous fluids, and antiemetics reduces the incidence and severity of IRRs
Purpose
- Evaluate the use of pre-treatment medications in patients with experienced IRRs at an outpatient infusion center
- Identify opportunities to improve treatment plans and reduce the occurrence of IRRs
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Pharmacy Posters
Introduction
- Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
- ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019
Purpose
- To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications